Dry AMD research was a hot topic at this year's ARVO annual meeting. Could ethically sourced stem cells from human embryos provide a solution to this challenging disease? Chris Riemann, MD, shared data from an early phase trial that sought to understand the safety of RPE cells surgically implanted below the retina.